These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 4806391)

  • 1. [Potentiation of the antitumoral activity of Daunomycin by Tween 80. In vivo and in vitro study on the ascitic Ehrlich tumor].
    Bossa R; Galatulas I; Piccinini F; Villani F
    G Ital Chemioter; 1973; 20(1-4):55-7. PubMed ID: 4806391
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytotoxic action of diethanolamine oleate on Ehrlich exudative carcinoma in mice, compared with the action of polyoxyethylene sorbitan mono-oleate (Tween 80).
    Witek R; Krupa S; Kubis A
    Arch Immunol Ther Exp (Warsz); 1979; 27(3):321-4. PubMed ID: 475555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytotoxic effect of Tween 80 on Ehrlich ascites cancer cells in mice.
    Kubis A; Witek R; Olszewski Z; Krupa S
    Pharmazie; 1979 Nov; 34(11):745-6. PubMed ID: 545345
    [No Abstract]   [Full Text] [Related]  

  • 4. The solvents cremophor EL and Tween 80 modulate daunorubicin resistance in the multidrug resistant Ehrlich ascites tumor.
    Friche E; Jensen PB; Sehested M; Demant EJ; Nissen NN
    Cancer Commun; 1990; 2(9):297-303. PubMed ID: 1976341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cystostatic efficacy of DNA-complexes of adriamycin, daunomycin, and actinomycin D. II. Comparative in vivo studies in an Ehrlich-ascites tumor.
    Seeber S; Schilcher RB; Brucksch KP; Käding J; Schmidt CG
    Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1977 Dec; 90(3):307-12. PubMed ID: 146332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concanavalin A as a carrier of daunomycin.
    Kitao T; Hattori K
    Nature; 1977 Jan; 265(5589):81-2. PubMed ID: 834249
    [No Abstract]   [Full Text] [Related]  

  • 7. Verapamil restoration of daunorubicin responsiveness in daunorubicin-resistant Ehrlich ascites carcinoma.
    Slater LM; Murray SL; Wetzel MW; Wisdom RM; DuVall EM
    J Clin Invest; 1982 Nov; 70(5):1131-4. PubMed ID: 6182160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytological and cytochemical analysis of Ehrlich ascites tumor cells treated with daunomycin.
    Bassleer R; Goessens G; Lepoint A; Desaive C; Kinet-Denoel C
    Beitr Pathol; 1973 Dec; 150(3):261-73. PubMed ID: 4771313
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparative study of the effect of valinomycin, triton X-100 and rotenone on the metabolism of Ehrlich ascitic tumor cells].
    Buzurbaev GG; Toktamysova ZS
    Tsitologiia; 1976 Aug; 18(8):1029-31. PubMed ID: 982599
    [No Abstract]   [Full Text] [Related]  

  • 10. Enhancement by cyclosporin A of daunorubicin efficacy in Ehrlich ascites carcinoma and murine hepatoma 129.
    Meador J; Sweet P; Stupecky M; Wetzel M; Murray S; Gupta S; Slater L
    Cancer Res; 1987 Dec; 47(23):6216-9. PubMed ID: 3677073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Potentiation of the anti-tumor activity of daunomycin by chloroimipramine].
    Bossa R; Dubini F; Galatulas I; Tofanetti O
    Arch Ital Patol Clin Tumori; 1970; 13(3):147-50. PubMed ID: 5521384
    [No Abstract]   [Full Text] [Related]  

  • 12. [Potentiation of the antitumor action of cyclophosphamide with a change in the cell population makeup and an increase in cellular permeability].
    Frankfurt OS
    Vopr Onkol; 1975; 21(10):63-7. PubMed ID: 1189353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Daunomycin pharmacological activity at the cellular level.
    Di Marco A
    Pathol Biol; 1967 Oct; 15(19):897-902. PubMed ID: 4297686
    [No Abstract]   [Full Text] [Related]  

  • 14. [Further experiments on antitumoral activity of etabetacin].
    Montagnani-Marelli A; Testorelli C; Valenti L
    Arch Ital Patol Clin Tumori; 1968; 11(3):301-10. PubMed ID: 5737810
    [No Abstract]   [Full Text] [Related]  

  • 15. Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma.
    Slater LM; Sweet P; Stupecky M; Wetzel MW; Gupta S
    Br J Cancer; 1986 Aug; 54(2):235-8. PubMed ID: 3741759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental studies on antineoplastic activity of daunomycin. I. Effect on experimental tumors].
    Nomiya B; Kagino K; Orikawa Y; Fujimori H
    Jpn J Antibiot; 1970 Apr; 23(2):171-80. PubMed ID: 5311043
    [No Abstract]   [Full Text] [Related]  

  • 17. Development of resistance to rubidazone (NSC-164011) in Ehrlich ascites tumor in vivo.
    Skovsgaard T
    Cancer Chemother Rep; 1975; 59(2 Pt 1):301-8. PubMed ID: 1149008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo study of cross resistance between daunorubicin and daunorubicin-DNA complex in Ehrlich ascites tumor.
    Skovsgaard T
    Cancer Chemother Pharmacol; 1979; 2(1):43-7. PubMed ID: 498419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross resistance between vinca alkaloids and anthracyclines in Ehrlich ascites tumor in vivo.
    Dano K
    Cancer Chemother Rep; 1972 Dec; 56(6):701-8. PubMed ID: 4660629
    [No Abstract]   [Full Text] [Related]  

  • 20. [Migration of tween 80-treated tumor cells].
    Lebedev KA; Kaulen DR; Khorobrykh VV; D'iakov GN; Simonova AV
    Vopr Onkol; 1977; 23(10):103-4. PubMed ID: 595524
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.